Underlying Causes and Treatment Modalities for Neurological Deficits in COVID-19 and Long-COVID.
ACS Chem Neurosci
; 13(20): 2934-2938, 2022 Oct 19.
Article
in English
| MEDLINE | ID: covidwho-2050258
ABSTRACT
With reports of diverse neurological deficits in the acute phase of COVID-19, there is a surge in neurological findings in Long-COVIDâa protracted phase of SARS-CoV-2 infection. Very little is known regarding the pathogenic mechanisms of Neuro-COVID in the above two settings in the current pandemic. Herein, we hint toward the possible molecular mechanism that can contribute to the signs and symptoms of patients with neurological deficits and possible treatment and prevention modalities in the acute and chronic phases of COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
ACS Chem Neurosci
Year:
2022
Document Type:
Article
Affiliation country:
Acschemneuro.2c00482
Similar
MEDLINE
...
LILACS
LIS